LFCR vs RHI · rev $75.5M vs P/E 21, rev $5.38B
Lifecore Biomedical Inc. (LFCR) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
LFCR currently screens at market cap $207.1M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the LFCR and RHI stock pages for the full models.
Not investment advice.